Sangamo Therapeutics(SGMO) - 2021 Q3 - Earnings Call Transcript

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2021 Earnings Conference Call November 4, 2021 9:15 AM ET Company Participants Aron Feingold – Head-Corporate Communications Sandy Macrae – Chief Executive Officer Prathyusha Duraibabu – Chief Financial Officer Bettina Cockroft – Chief Medical Officer Rob Schott – Head-Development Mark McClung – Chief Operating Officer Conference Call Participants Aspen Mori – Bank of America Yanan Zhu – Wells Fargo Luca Issi – RBC Capital Maury Raycroft – Jefferies Nicole Germino ...